| Code | 2329E | ||||||||||
| MA number | 87/0275/22-S | ||||||||||
| Product Form: | pas ocp 20(1x20)x4 mg (obal PP+vysúšadlo) | ||||||||||
| MA Status: | R - Valid Marketing Authorisation | ||||||||||
| Type of procedure: | Mutual recognition procedure | ||||||||||
| MAH, country: | McNeil AB, Sweden | ||||||||||
| Therapeutic Class: | 87 - VARIA I | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 36 | ||||||||||
| Route of admin.: | Oromucosal use |
| Prescription Status: | Medicinal product not subject to medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA issued: | 30.11.2022 |
| Validity: | 30.11.2027 |
| Pediatric posology: | Yes |
| Pediatric contraindication: | Yes |
| Pediatric warnings: | Yes |
| SPC: |
SPC_Nicorette Mint 4 mg_03.2025.pdf
|
| PIL: |
PIL_Nicorette Mint 4 mg_05/2025.pdf
|
| Safety feature | No |
| Data update: | 17.01.2024 |
